glp-1 medications approved for diabetes and weight loss 2025 What are GLP-1s? World Health Organization issues first-ever

101117251 (OBECAUSE)

Diz-Chaves Y, Herrera-Prez S, Gonzlez-Matas LC, et al

Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: A potential mechanism for veno-occlusive dysfunction in androgen deficiency

[DOI] [PubMed] [Google Scholar] 68.Komatsu R, Matsuyama T, Namba M, et al

Market Opportunity : Major opportunities include oral GLP-1 innovations, combination therapies integrating GIP/GLP-1 pathways, improved affordability for emerging markets, expanding indications beyond diabetes and obesity, and partnerships to enhance manufacturing capacity, distribution, and long-term patient adherence